Posts

How to Learn Pharmacovigilance Step by Step

How to Learn Pharmacovigilance Step by Step: A Complete Beginner's Guide 2026

-
Image
How to Learn Pharmacovigilance Step by Step: A Complete Beginner's Guide 2026 If you have just started exploring pharmacovigilance, you probably know the feeling — there is a lot of information out there, but it is hard to know where to begin. Do you start with adverse drug reactions? Or regulatory guidelines? Or case processing? The truth is, pharmacovigilance has a natural learning order. Jumping into signal detection before understanding what an ICSR is will only make things more confusing. This guide is designed to give you a clear, logical roadmap — step by step — so that every new concept builds on what you already know. Whether you are a pharmacy graduate, a life sciences student, or someone switching careers into drug safety, this complete guide will walk you through everything you need to learn. Quick Navigation What is Pharmacovigilance Key Terminologies Adverse Drug Reactions ICSR Processing Causality Assessment Narrative Writing Medical Coding Regulatory Reporting Agg...
Post a Comment
Read more

ICSR Case Challenge #2: Serious vs Non-Serious (Case Scenarios + Interview-Level Thinking)

-
  🧪 ICSR Case Challenge #2: Serious vs Non-Serious (Case Scenarios + Interview-Level Thinking) 📢 From Theory → Real Pharmacovigilance Decision-Making After understanding how to identify a valid ICSR , the next critical step in pharmacovigilance is: 👉 Determining whether a case is Serious or Non-Serious This is not just a theoretical concept—it directly impacts: Regulatory reporting timelines Case processing priority Compliance with global pharmacovigilance guidelines If you are preparing for pharmacovigilance roles, this is one of the most frequently tested and commonly misunderstood topics . 📌 Before You Start If you're new or want to strengthen your basics, review these first: 👉  ICSR Case Processing   👉 PV Terminologies 👉 Seriousness Vs Severity  These will help you connect theory with the case-based thinking below. 💡 Serious vs Severity: The Most Common Confusion Let’s address the biggest mistake beginners make: ❌ “Severe symptoms = Serious case” 👉 This...
Post a Comment
Read more

ICSR Case Example: Valid or Invalid? Pharmacovigilance Practice Scenario for Beginners

-
ICSR Case Example: Valid or Invalid? Pharmacovigilance Practice Scenario for Beginners 🧪 ICSR Case Challenge #1: Valid or Invalid? 📢 New Series: From Theory → Real Case Thinking Most pharmacovigilance learners spend a lot of time understanding concepts—but struggle when it comes to applying them in real scenarios. If you’ve gone through topics like: Introduction to Pharmacovigilance ICSR Processing Workflow Key PV Terminologies …but still feel unsure while evaluating cases, you’re not alone. 👉 That’s exactly why I’m starting this ICSR Case Challenge Series This series is designed to help you: Apply theoretical knowledge to real-like cases Think like a pharmacovigilance professional Prepare for interviews and practical tasks 📌 If you’re new, you can first explore: Introduction to Pharmacovigilance ICSR Processing Step-by-Step Workflow Minimum Criteria for ICSR Then come back and test yourself here. 💡 Tip: Try answering before scrolling—this is how real PV decisions are made. ⚠️ Qu...
Post a Comment
Read more

Spontaneous Reporting vs Active Surveillance in Pharmacovigilance (Examples & Key Differences)

-
Image
Spontaneous Reporting vs Active Surveillance in Pharmacovigilance (Examples & Key Differences) Introduction to Drug Safety Monitoring Ensuring the safety of medicines is a critical part of modern healthcare. Even after a medicine receives regulatory approval and becomes available to patients, its safety must continue to be monitored in real-world clinical use. This ongoing safety monitoring process is known as pharmacovigilance, which focuses on detecting, assessing, understanding, and preventing adverse effects related to medicines. If you are new to the field, you can first understand the fundamentals in Introduction to Pharmacovigilance (PV): Definition, History, and Key Concepts for Beginners. A major focus of pharmacovigilance is the identification and evaluation of adverse drug reactions (ADRs) reported by healthcare professionals, patients, or pharmaceutical companies. To understand ADR concepts in detail, you can explore Adverse Drug Reactions (ADR): Types, Minimum Criteria...
Post a Comment
Read more

How to Identify ICSRs in Medical Literature: Step-by-Step Guide for Pharmacovigilance Professionals

-
Image
How to Identify ICSRs in Medical Literature: Step-by-Step Guide for Pharmacovigilance Professionals Literature screening is a major pillar of pharmacovigilance (PV) . It ensures that potential adverse drug reactions reported in scientific publications are captured, evaluated, and reported to regulators. For Marketing Authorization Holders (MAHs), effective literature monitoring is not optional — it is a regulatory obligation.  This process, often referred to as literature screening in pharmacovigilance , is essential for timely safety detection. This guide explains how to identify Individual Case Safety Reports (ICSRs) in literature , based on practical workflow concepts and regulatory expectations, along with real examples and a reviewer checklist.
Post a Comment
Read more

Importance of Pharmacovigilance in Clinical Trials: Key Safety Activities and Regulatory Requirements

-
Importance of Pharmacovigilance in Clinical Trials: Key Safety Activities and Regulatory Requirements Pharmacovigilance (PV) during clinical trials encompasses the science and activities related to the detection, assessment, understanding, and prevention of adverse events and other drug-related problems associated with investigational products.  During clinical development, the safety profile of a new drug continues to evolve; therefore, systematic safety monitoring is essential to protect trial participants and ensure the reliability of clinical data.  Pharmacovigilance activities begin with the first administration of an investigational product in humans and continue throughout all phases of development. Furthermore, clinical trials typically involve limited and selected populations, making continuous safety surveillance critical for the early identification of potential risks.  In accordance with ethical principles such as the Declaration of Helsinki and Good Clinical ...
Post a Comment
Read more